Skip to content
  • Clinical Studies
  • Pharma GMP
  • Pharma Tips
  • Stability Studies
  • Pharma Books
  • Schedule M

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Content Uniformity in Tablets

Posted on By

SOP for Content Uniformity in Tablets

Procedure for Content Uniformity in Tablets

1) Purpose

The purpose of this SOP is to outline the procedure for testing content uniformity in finished tablets to ensure each tablet contains the correct amount of active pharmaceutical ingredient (API) within specified limits.

2) Scope

This SOP applies to all tablet formulations manufactured within the facility that require content uniformity testing as per regulatory requirements.

3) Responsibilities

Quality Control (QC) Department: Responsible for conducting content uniformity testing and ensuring compliance with this SOP.
Production Department: Responsible for providing tablet samples and supporting QC during testing.

See also  SOP for Metered Dose Inhaler (MDI) Performance Testing

4) Procedure

4.1 Sample Selection:
    4.1.1 Select representative samples of finished tablets from different batches.
    4.1.2 Ensure samples are taken randomly and cover the entire batch production.

4.2 Sample Preparation:
    4.2.1 Disintegrate tablets to obtain a homogenous sample of API.
    4.2.2 Prepare sample solutions or suspensions as per validated methods and dilutions if necessary.
    4.2.3 Ensure samples are properly identified, labeled, and stored under appropriate conditions.

4.3 Content Uniformity Testing:
    4.3.1 Analyze individual tablets or sample solutions using validated analytical methods, such as HPLC or UV-Vis spectroscopy.
    4.3.2 Determine API content in each tablet or sample solution.
    4.3.3 Calculate the mean and relative standard deviation (RSD) of API content across the sample

set.
    4.3.4 Compare results against acceptance criteria specified in pharmacopeial standards or internal specifications.

See also  SOP for Capsule Content Uniformity

4.4 Calculation and Interpretation:
    4.4.1 Calculate the mean content and RSD using validated formulas.
    4.4.2 Evaluate content uniformity results to ensure compliance with specified limits.
    4.4.3 Investigate and document any deviations from expected results, including outliers or non-uniformity.

4.5 Acceptance Criteria:
    4.5.1 Tablets are considered uniform if the RSD of API content does not exceed predefined limits.
    4.5.2 Ensure all analytical controls and method validation parameters meet predefined criteria.

4.6 Documentation:
    4.6.1 Record all content uniformity testing procedures, results, and observations in the Content Uniformity Testing Record.
    4.6.2 Maintain detailed records of sample preparation, testing conditions, and any deviations encountered.
    4.6.3 Review and approve the documentation by QC Manager.

See also  SOP for Powder Density Testing

5) Abbreviations, if any

QC: Quality Control
API: Active Pharmaceutical Ingredient
HPLC: High Performance Liquid Chromatography
UV-Vis: Ultraviolet-Visible Spectroscopy
RSD: Relative Standard Deviation

6) Documents, if any

Content Uniformity Testing Record
Method Validation Report for Content Uniformity
Sampling Plan Document

7) Reference, if any

USP General Chapter <905> – Uniformity of Dosage Units
Pharmacopeial standards for Content Uniformity in Tablets

8) SOP Version

Version 1.0

In-Process Control Tags:Blend uniformity testing SOP, Bulk density testing SOP, Capsule content uniformity SOP, Capsule disintegration testing SOP, Capsule dissolution testing SOP, Capsule weight variation SOP, Clarity and opalescence testing of liquids SOP, Endotoxin testing in injectable products SOP, Flowability testing of powders SOP, Granulation size distribution SOP, Moisture content determination in granules SOP, Osmolality testing SOP, Particulate matter testing in liquids SOP, pH measurement of solutions SOP, Pyrogen testing SOP, Specific gravity testing of liquids SOP, Sterility testing SOP, Tablet disintegration testing SOP, Tablet dissolution testing SOP, Tablet friability testing SOP, Tablet hardness testing SOP, Tablet thickness measurement SOP, Tablet weight variation SOP, Uniformity of dosage units SOP, Viscosity testing of liquids SOP

Post navigation

Previous Post: SOP for Batch Record Review in Ointment Formulation
Next Post: SOP for Content Uniformity in Capsules

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version